The US Supreme Court seems likely to rule for Merck & Co. Inc. in a case addressing whether FDA rejection of a manufacturer's proposed label warning preempts state-law tort suits claiming the manufacturer failed to adequately warn of the product's risks.
During Jan. 7 oral argument in Merck Sharp & Dohme Corp. v. Albrecht, Chief Justice John Roberts Jr. and Justices...




